TipRanks on MSN
Regeneron price target raised to $985 from $890 at HSBC
HSBC raised the firm’s price target on Regeneron (REGN) to $985 from $890 and keeps a Buy rating on the shares as part of a ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...
Fintel reports that on December 4, 2025, Canaccord Genuity maintained coverage of Regeneron Pharmaceuticals (NasdaqGS:REGN) with a Buy recommendation. Analyst Price Forecast Suggests 7.03% Upside As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results